Clinical studies recruiting near Girona

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Hospital Universitari De Girona Doctor Josep Trueta · Pfizer · NCT05020236 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Institut Català d'Oncologia (ICO) - Girona · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Girona University Hospital · Joseph Broderick, MD · NCT07227246 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Institut Català d'Oncologia (ICO) - Girona ( Site 3002) · Merck Sharp & Dohme LLC · NCT07216703 Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · Institut Català d'Oncologia (ICO) Girona · SOLTI Breast Cancer Research Group · NCT07371585 Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1/Phase 2 · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · OSE Immunotherapeutics · NCT05751798 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Hosp. Univ. Dr. Josep Trueta · Janssen Research & Development, LLC · NCT07499232 Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.
NA · Clínica Girona · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT04330846 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · ICO Girona, Hospital Josep Trueta · Fundación GECP · NCT05398094 Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Phase 4 · Hospital Universitario Dr. Josep Trueta · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT05761080 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Hospital Universitari Doctor Josep Trueta- ICO de Girona · Artios Pharma Ltd · NCT04657068 IVR ON UPPER-LIMB REHABILITATION IN STROKE PATIENTS: A CLINICAL TRIAL
NA · Hospital Dr Josep Trueta · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · NCT07609966 A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcuta
Phase N/A · Hospital De Santa Caterina /ID# 280913 · AbbVie · NCT07284342 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Takeda · NCT06499285 Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis
Phase N/A · Institut d'Investigació Biomèdica de Girona (IDIBGI) · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · NCT06869941 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · Gerona, Cataluña Investigative Site FIN-38017 · Colorado Prevention Center · NCT06033950 A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injectio
Phase 1 · GSK Investigational Site · GlaxoSmithKline · NCT06431594 Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurys
Phase N/A · Hospital Universitari de Girona Doctor Josep Trueta · Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd · NCT07674173 Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
Phase 2 · Institut Català d'Oncologia Girona - ICO Girona · MedSIR · NCT07195227 Thoracic Tumours Register
Phase N/A · Hospital Dr. Josep Trueta · Spanish Lung Cancer Group · NCT02941458 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Institut Català d'Oncologia de Girona. · Boehringer Ingelheim · NCT07472517 A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT
Phase 3 · Institut Català d'Oncologia (ICO) - Girona-Oncología Médica · Merck Sharp & Dohme LLC · NCT07554339 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Phase 2 · Institut Català d'Oncologia Girona · Karyopharm Therapeutics Inc · NCT05980806 Evaluation of the Perfusion of the Pancreatic Remnant With Indocyanine Green and Its Impact on the Reduction of Pancreat
NA · Hospital Universitari Dr. Josep Trueta de Girona · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · NCT07502053 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NA · ICO-Dr.Josep Trueta · PETHEMA Foundation · NCT04179929 A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure
Phase 2 · Hospital Univ. de Gerona Doctor Josep Trueta · Novo Nordisk A/S · NCT06979375 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site ES34011 · Astellas Pharma Global Development, Inc. · NCT02960022 Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Phase N/A · Hospital Universitari Dr. Josep Trueta/Institut Català D'Onc · Fundación Sociedad Española de Oncologia Médica · NCT03855592 Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Phase 3 · Hospital Universitario Josep Trueta · Iperboreal Pharma Srl · NCT03994471

Look up another city

Look up another condition